Nadia Vié

527 total citations
10 papers, 362 citations indexed

About

Nadia Vié is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nadia Vié has authored 10 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nadia Vié's work include Cancer therapeutics and mechanisms (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). Nadia Vié is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). Nadia Vié collaborates with scholars based in France, Netherlands and United Kingdom. Nadia Vié's co-authors include Céline Gongora, Pierre Martineau, Maguy Del Rio, Caroline Mollévi, Bruno Robert, Vincent Denis, Franck Molina, Virginie Copois, Nicole Bec and Caroline Fraslon and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Molecular Cancer.

In The Last Decade

Nadia Vié

9 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Vié France 7 201 164 105 54 42 10 362
Mesquita Rodrigues Portugal 6 251 1.2× 115 0.7× 194 1.8× 35 0.6× 15 0.4× 7 385
Laura Ghisolfi United States 7 219 1.1× 163 1.0× 115 1.1× 37 0.7× 16 0.4× 10 356
Pinjie Bao Japan 10 221 1.1× 149 0.9× 106 1.0× 62 1.1× 20 0.5× 10 338
Joanne Berry United Kingdom 4 415 2.1× 100 0.6× 99 0.9× 34 0.6× 26 0.6× 4 516
Florence Giffard France 13 320 1.6× 90 0.5× 173 1.6× 54 1.0× 24 0.6× 23 454
James T. Topham Canada 8 153 0.8× 149 0.9× 148 1.4× 51 0.9× 14 0.3× 37 321
Debora Malpicci Italy 7 285 1.4× 126 0.8× 212 2.0× 42 0.8× 11 0.3× 9 401
Flavien Devun France 11 307 1.5× 137 0.8× 69 0.7× 56 1.0× 23 0.5× 16 386
Meghan M. Morrison United States 7 185 0.9× 171 1.0× 69 0.7× 36 0.7× 48 1.1× 8 380
Linwei Guo China 7 276 1.4× 175 1.1× 221 2.1× 117 2.2× 22 0.5× 10 468

Countries citing papers authored by Nadia Vié

Since Specialization
Citations

This map shows the geographic impact of Nadia Vié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Vié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Vié more than expected).

Fields of papers citing papers by Nadia Vié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Vié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Vié. The network helps show where Nadia Vié may publish in the future.

Co-authorship network of co-authors of Nadia Vié

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Vié. A scholar is included among the top collaborators of Nadia Vié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Vié. Nadia Vié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vié, Nadia, et al.. (2025). Shining light on drug discovery: optogenetic screening for TopBP1 biomolecular condensate inhibitors. NAR Cancer. 7(4). zcaf041–zcaf041.
2.
Garambois, Véronique, Nelly Pirot, Charles Theillet, et al.. (2021). Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models. mAbs. 13(1). 1914883–1914883. 7 indexed citations
3.
Ogier, Charline, Pierre‐Emmanuel Colombo, Corinne Bousquet, et al.. (2018). Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Letters. 432. 227–236. 43 indexed citations
4.
Andrade, Augusto Faria, Jérôme Moreaux, Nadia Vié, Maguy Del Rio, & Céline Gongora. (2018). PO-481 Alteration in epigenetic-related genes and histones modifications levels revealed as a potential resistance factor to oxaliplatin in colorectal cancer cells. ESMO Open. 3. A210–A211. 1 indexed citations
5.
Tosi, Diégo, Nadia Vié, Christel Larbouret, et al.. (2018). Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment. BMC Cancer. 18(1). 812–812. 17 indexed citations
6.
Rio, Maguy Del, Caroline Mollévi, Frédéric Bibeau, et al.. (2017). Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. European Journal of Cancer. 76. 68–75. 70 indexed citations
7.
Tosi, Diégo, Pierre Martineau, Maguy Del Rio, et al.. (2017). Abstract 1187: Synthetic lethality screening reveals ATR as responsible for oxaliplatin resistance in colorectal cancer cells. Cancer Research. 77(13_Supplement). 1187–1187. 1 indexed citations
8.
Marzi, Laetitia, Nadia Vié, Diégo Tosi, et al.. (2016). FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer. British Journal of Cancer. 115(10). 1223–1233. 44 indexed citations
9.
Lazrek, Yassamine, Olivier Dubreuil, Véronique Garambois, et al.. (2013). Anti-HER3 Domain 1 and 3 Antibodies Reduce Tumor Growth by Hindering HER2/HER3 Dimerization and AKT-Induced MDM2, XIAP, and FoxO1 Phosphorylation. Neoplasia. 15(3). 335–IN40. 35 indexed citations
10.
Vié, Nadia, Virginie Copois, Caroline Mollévi, et al.. (2008). Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Molecular Cancer. 7(1). 14–14. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026